Archive Newsletter
-
10.27.26 -- Advancing Cell Therapy Toward A Functional Cure For T1D With Forthcoming BetaNova's Jonathan Rigby And Will Rust, Ph.D.
10/27/2026
10/27/26 Cell & Gene Newsletter
-
10.27.26 -- The 5 Shifts That Could Remake Lyophilization By 2040
10/27/2026
10/27/26 Cell & Gene Newsletter
-
10.26.26 -- OPCU: Fill/Finish Strategies For Protecting Advanced Therapy Products
10/26/2026
10/26/26 Cell & Gene Newsletter
-
10.26.26 -- Breaking Down Development Silos In In Vivo CGT Manufacturing
10/26/2026
10/26/26 Cell & Gene Newsletter
-
10.23.26 -- Digitalization And Traceability Reshaping Cleanroom Compliance
10/23/2026
10/23/26 Cell & Gene Newsletter
-
10.23.26 -- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
10/23/2026
10/23/26 Cell & Gene Newsletter
-
10.22.26 -- AI And Viral Vector Innovations Shaping Cell And Gene Therapy
10/22/2026
10/22/26 Cell & Gene Newsletter
-
10.22.26 -- Is Your Manufacturing Process Ready For MES?
10/22/2026
10/22/26 Cell & Gene Newsletter
-
10.21.26 -- Reduce risk. Move Annex 1 forward.
10/21/2026
10/21/26 Cell & Gene Newsletter
-
10.21.26 -- Sterile Manufacturing Under Scrutiny: Glove Integrity, Residue, And Hidden Contamination
10/21/2026
10/21/26 Cell & Gene Newsletter